Related references
Note: Only part of the references are listed.The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
Katarina D. Kovacevic et al.
HAEMATOLOGICA (2022)
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies
Michael U. Callaghan et al.
BLOOD (2021)
Mortality in congenital hemophilia A - a systematic literature review
Charles R. M. Hay et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients
Katarina D. Kovacevic et al.
SCIENTIFIC REPORTS (2021)
Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective
Francesca Tomeo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database
Olav Versloot et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Incidence and mortality rates of intracranial hemorrhage in hemophilia: a systematic review and meta-analysis
Anne-Fleur Zwagemaker et al.
BLOOD (2021)
Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues
Frank W. G. Leebeek et al.
BLOOD (2021)
Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control study
Amal Abdi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH
Karin P. M. van Galen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Hemophilia Gene Therapy: Approaching the First Licensed Product
Paul Batty et al.
HEMASPHERE (2021)
Investigating the clearance of VWF A-domains using site-directed PEGylation and novel N-linked glycosylation
Judicael Fazavana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer
Shuhao Zhu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project
Dagmar M. Hajducek et al.
HAEMOPHILIA (2020)
WFH Guidelines for the Management of Hemophilia, 3rd edition
Alok Srivastava et al.
HAEMOPHILIA (2020)
Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia A
Georg Gelbenegger et al.
THROMBOSIS AND HAEMOSTASIS (2020)
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A
Barbara A. Konkle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Inhibitors and mortality in persons with nonsevere hemophilia A in the United States
Ming Y. Lim et al.
BLOOD ADVANCES (2020)
Burden of mild haemophilia A: Systematic literature review
Flora Peyvandi et al.
HAEMOPHILIA (2019)
Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males A Meta-analytic Approach Using National Registries
Alfonso Iorio et al.
ANNALS OF INTERNAL MEDICINE (2019)
Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years
Mehdi Osooli et al.
HAEMOPHILIA (2019)
Automated assays for von Willebrand factor activity
Russell A. Higgins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study
Martin J. Scott et al.
HAEMOPHILIA (2019)
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH
M. V. Ragni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
J. Mahlangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding
Victoria Candy et al.
BLOOD ADVANCES (2018)
The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B
J. Michael Soucie et al.
BLOOD ADVANCES (2018)
Pharmacokinetics, pharmacodynamics and safety of aptamers
Katarina D. Kovacevic et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations
Alfonso Iorio et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden
M. Osooli et al.
HAEMOPHILIA (2017)
Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophiliaA or B using a population pharmacokinetic approach: communication from the SSC of the ISTH
A. Iorio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A
Steven W. Pipe et al.
BLOOD (2016)
Development of a Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo): Study Protocol
Alfonso Iorio et al.
JMIR RESEARCH PROTOCOLS (2016)
Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD
Veronica H. Flood et al.
BLOOD (2011)
High incidence of ankle arthropathy in mild and moderate haemophilia A
Min Ling et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Desmopressin in mild hemophilia A: Indications, limitations, efficacy, and safety
S Lethagen
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2003)
Medical progress - The hemophilias - From royal genes to gene therapy
PM Mannucci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Definitions in hemophilia - Recommendation of the Scientific Subcommittee on factor VIII and factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
GC White et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Localization of von Willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanning mutagenesis
T Matsushita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
